Nektar Therapeutics
NKTR
$0.8968
$0.08149.98%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 29.23% | -42.28% | 12.54% | 8.20% | 10.34% |
| Total Depreciation and Amortization | -31.94% | -9.21% | -2.72% | -2.54% | -21.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -473.57% | 139.51% | -221.61% | -135.93% | -22.64% |
| Change in Net Operating Assets | -89.87% | 263.16% | -39.92% | -46.32% | 65.45% |
| Cash from Operations | -16.52% | 21.27% | -1.79% | -11.69% | 18.25% |
| Capital Expenditure | -258.06% | -18.47% | 33.76% | -618.18% | 79.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 172.50% | -11.57% | 10.19% | -68.08% | 117.90% |
| Cash from Investing | 171.56% | -11.82% | 10.79% | -69.19% | 124.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -31.58% | 533.33% | -75.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Financing | -31.58% | -99.95% | 349,925.00% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -2,700.00% | 87.50% | -200.00% | 108.16% | -191.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.48% | -254.90% | 145.09% | -308.86% | 154.12% |
